Featured image for “Oscar Sanchez brings 30 years of Experience to Help Drive Envol To GLP in 2025”

Oscar Sanchez brings 30 years of Experience to Help Drive Envol To GLP in 2025

December 12, 2023

We’re excited to welcome Oscar Sanchez to the team at Envol Biomedical!

He has over 30 years of experience in the pharmaceutical, medical device, and biotechnology industries as a quality assurance, regulatory affairs, and operations expert. He has served as the Head of Quality for Novartis, Vice President of Quality Drug Products for AMRI, and Vice President of Quality for Reata Pharmaceuticals and Amag Pharmaceuticals. Oscar has been integral to obtaining New Drug Application (NDA) approval for 6 new drug entities in the last 5 years, including Preclinical GLP.

Mr. Sanchez has led manufacturing and vivarium quality systems, including for global companies at sites worldwide. At Envol he will be responsible for leading our efforts to establish a GLP quality system to comply with global GLP requirements in 2025. Oscar will also ensure compliance with our animal welfare, safety, and environmental efforts.


Share: